Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[The coxibs, third generation anti-inflammatories].

¹Chargé de Missions Hôpital Erasme et C.U.M.G.-U.L.B.

Revue Medicale De Bruxelles

|June 5, 2001

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Traitement Des Infections Bronchopulmonaires Aigues Par Le Laurylsulfate De Tetracycline Intra-Musculaire.

Acta clinica Belgica·2016

Same author

[Varenicline: an aid to smoking cessation therapy].

Revue medicale de Bruxelles·2008

Same author

[Inhaled human insulin (Exubera): a revolution?].

Revue medicale de Bruxelles·2007

Same author

[Combination of Zocor with Ezetrol].

Revue medicale de Bruxelles·2007

Same author

[The war on generic drugs].

Revue medicale de Bruxelles·2006

Same author

[Pregabalin (Lyrica) and neuropathic pain syndromes].

Revue medicale de Bruxelles·2006

Same journal

[Breast cancer screening : a tool for informed decision making].

Revue medicale de Bruxelles·2018

Same journal

[Breast cancer screening : present situation and prospects].

Revue medicale de Bruxelles·2018

Same journal

[Guidelines in medical imaging : objectives, limits and radiation protection].

Revue medicale de Bruxelles·2018

Same journal

[How to avoid overmedicalization of the elderly patient ?]

Revue medicale de Bruxelles·2018

Same journal

[Ethical, pedagogical, socio-political and anthropological implications of quaternary prevention].

Revue medicale de Bruxelles·2018

Same journal

[New strategies in specific care for benign prostatic hypertrophy in older men].

Revue medicale de Bruxelles·2018

See all related articles

Coxibs, a type of anti-cyclooxygenase-2 (COX-2) inhibitor, offer comparable anti-inflammatory effects to NSAIDs with reduced gastrointestinal toxicity. Their use in rheumatic conditions requires careful consideration of risks, costs, and patient-specific factors.

Area of Science:

Rheumatology
Gastroenterology
Pharmacology

Context:

Rheumatic conditions often require non-steroidal anti-inflammatory drugs (NSAIDs).
Patients with rheumatic diseases frequently have gastrointestinal ulcer risks.
Traditional NSAIDs carry significant gastrointestinal toxicity concerns.

Purpose:

To evaluate the role of coxibs as selective anti-cyclooxygenase-2 (COX-2) agents in managing rheumatic conditions.
To compare the efficacy and gastrointestinal safety profile of coxibs against traditional NSAIDs.
To assess the overall risk-benefit ratio and cost-effectiveness of coxibs in specific patient populations.

Summary:

Coxibs demonstrate anti-inflammatory efficacy comparable to NSAIDs.
Selective COX-2 inhibitors exhibit a lower risk of gastrointestinal mucosal toxicity compared to non-selective NSAIDs.

Related Experiment Videos

Adverse effects, contraindications, and drug interactions of coxibs are similar to other NSAIDs, necessitating careful patient selection and monitoring.

The cost-benefit analysis suggests coxibs may be a reasonable option for patients with rheumatic conditions and gastrointestinal risks.

Impact:

Coxibs represent a valuable therapeutic evolution for rheumatic patients at risk of gastrointestinal ulcers.
Selective COX-2 inhibition offers a safer alternative for managing pain and inflammation in susceptible individuals.
Long-term pharmacovigilance is crucial to fully understand the safety and efficacy of coxibs in clinical practice.